iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
about
iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@en
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@nl
type
label
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@en
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@nl
prefLabel
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@en
iTRAQ Quantitative Proteomic P ...... n a 3D Printed Fluidic Device.
@nl
P2860
P1433
P1476
iTRAQ Quantitative Proteomic P ...... in a 3D Printed Fluidic Device
@en
P2093
C Bruce Mousseau
Katelyn R Ludwig
P2860
P304
P356
10.1021/ACS.ANALCHEM.7B04969
P407
P577
2017-12-21T00:00:00Z